CA
NZ
UK
AU
IND
US
Erin Burr, CRO and CRA Officer and Executive Vice President of FS Bancorp, Inc. (NASDAQ:FSBW), filed a Form 4 on August 17, 2026, disclosing changes in beneficial ownership as of August 14, 2026.
David L. Orf, Executive Vice President and Chief Compliance Officer of Commerce Bancshares Inc /MO/ (NASDAQ:CBSH), filed a Form 4 on August 18, 2026, disclosing multiple transactions in the company's common stock dated August 14, 2026.
A Form 4 filed on August 18, 2026 with the SEC discloses that James P. Geary II, a director of Burke & Herbert Financial Services Corp. (NASDAQ:BHRB), sold shares of common stock on August 14, 2026 through the JPG Trust.
Eric W. Gerstenberg, Co-CEO of Clean Harbors Inc, filed a Form 4 on August 18, 2026, reporting the sale of 2,500 shares of common stock on August 14, 2026.
A Form 4 filed with the SEC on August 18, 2026 discloses that Lorin L. Brass, a director of Bristow Group Inc. (NYSE:VTOL), sold 210 shares of common stock on August 17, 2026 at a weighted average price of $46.7754 per share.
Terry Lynn Williams, Chief Information Officer of Associated Banc-Corp, filed a Form 4 on August 18, 2026, disclosing the acquisition of common stock through the company's Employee Stock Purchase Plan on August 17, 2026.
Anthony P J Smurfit, President and Group CEO of Smurfit Westrock plc, filed a Form 4 on August 18, 2026, reporting the acquisition of 784 ordinary shares on August 14, 2026, through dividend equivalent accruals on an existing restricted stock unit award.
A Form 4 filed on August 18, 2026 reports that Ken Bowles, Executive Vice President and Group CFO of Smurfit Westrock plc (NYSE:SW), acquired 234 ordinary shares via dividend-equivalent restricted stock units on August 14, 2026.
The York Water Company filed a Form 8-K on August 18, 2026, disclosing the appointment of Mr. David M. Velazquez as a new independent director to its Board of Directors, effective September 1, 2026.
A Form 4 filed on August 18, 2026, disclosed that John S. Montalbano, a director of AbCellera Biologics Inc. (NASDAQ:ABCL), purchased 10,000 common shares on August 18, 2026.
Please wait processing your request...